Article citationsMore>>

Whiting, R.L., Choppin, A., Luehr, G. and Jasper, J.R. (2021) Preclinical Evaluation of the Effects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D2/D3 Receptor Antagonist for the Management of Gastroparesis. Journal of Pharmacology and Experimental Therapeutics, 379, 85-95.
https://doi.org/10.1124/jpet.121.000698

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top